Myocardial Injection of Apelin-Overexpressing Bone Marrow Cells Improves Cardiac Repair via Upregulation of Sirt3 after Myocardial Infarction

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Li, Lanfang ^a   Zeng, Heng ^a   Hou, Xuwei ^a   He, Xiaochen ^a   Chen, Jian Xiong ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; APELIN; CHEMOKINE RECEPTOR CXCR4; NOTCH3 RECEPTOR; REACTIVE OXYGEN METABOLITE; SIRTUIN 3; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL THERAPY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE FIBROSIS; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANGIOGENIC PROTEINS; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CARDIOMEGALY; CELLS, CULTURED; CORONARY VESSELS; ENZYME INDUCTION; FIBROSIS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; REACTIVE OXYGEN SPECIES; REGENERATION; SIRTUIN 3; UP-REGULATION;

EID: 84883615107     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071041     Document Type: Article

References (40)

1. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, et al. (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44: 1690-1699.
2. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, et al. (2003) Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108: 2212-2218.
3. Jujo K, Ii M, Losordo DW, (2008) Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 45: 530-544.
4. Hu CH, Li ZM, Du ZM, Zhang AX, Rana JS, et al. (2010) Expanded human cord blood-derived endothelial progenitor cells salvage infarcted myocardium in rats with acute myocardial infarction. Clin Exp Pharmacol Physiol 37: 551-556.
5. Cho J, Zhai P, Maejima Y, Sadoshima J, (2011) Myocardial injection with GSK-3beta-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction. Circ Res 108: 478-489 CIRCRESAHA.110.229658 [pii]; doi:10.1161/CIRCRESAHA.110.229658.
6. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, et al. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201 nm912 [pii]. doi:10.1038/nm912.
7. Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, et al. (2007) Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Res Cardiol 102: 518-528.
8. Zeng XJ, Zhang LK, Wang HX, Lu LQ, Ma LQ, et al. (2009) Apelin protects heart against ischemia/reperfusion injury in rat. Peptides 30: 1144-1152.
9. Kleinz MJ, Baxter GF, (2008) Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase. Regul Pept 146: 271-277 S0167-0115(07)00206-6 [pii]; doi:10.1016/j.regpep.2007.10.002.
10. Rastaldo R, Cappello S, Folino A, Berta GN, Sprio AE, et al. (2011) Apelin-13 limits infarct size and improves cardiac postischemic mechanical recovery only if given after ischemia. Am J Physiol Heart Circ Physiol 300: H2308-H2315 ajpheart.01177.2010 [pii]; doi:10.1152/ajpheart.01177.2010.
11. Gao LR, Xu RY, Zhang NK, Chen Y, Wang ZG, et al. (2009) Increased apelin following bone marrow mononuclear cell transplantation contributes to the improvement of cardiac function in patients with severe heart failure. Cell Transplant 18: 1311-1318 ct2160gao [pii]; doi:10.3727/096368909X474843.
12. Zeng XX, Wilm TP, Sepich DS, Solnica-Krezel L, (2007) Apelin and its receptor control heart field formation during zebrafish gastrulation. Dev Cell 12: 391-402.
13. Inui M, Fukui A, Ito Y, Asashima M, (2006) Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis. Dev Biol 298: 188-200 S0012-1606(06)00934-1 [pii]; doi:10.1016/j.ydbio.2006.06.028.
14. Zeng X, Yu SP, Taylor T, Ogle M, Wei L, (2011) Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis. Stem Cell Res 8: 357-367 S1873-5061(11)00164-4 [pii]; doi:10.1016/j.scr.2011.12.004.
15. Li L, Zeng H, Chen JX, (2012) Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am J Physiol Heart Circ Physiol 303: H605-H618 ajpheart.00366.2012 [pii]; doi:10.1152/ajpheart.00366.2012.
16. Rose G, Dato S, Altomare K, Bellizzi D, Garasto S, et al. (2003) Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp Gerontol 38: 1065-1070 S0531556503002092 [pii].
17. Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y, (2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 282: 6823-6832 M609554200 [pii]; doi:10.1074/jbc.M609554200.
18. Sundaresan NR, Samant SA, Pillai VB, Rajamohan SB, Gupta MP, (2008) SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol Cell Biol 28: 6384-6401 MCB.00426-08 [pii]; doi:10.1128/MCB.00426-08.
19. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, et al. (2009) Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 119: 2758-2771 39162 [pii]; doi:10.1172/JCI39162.
20. Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, et al. (2010) Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem 285: 3133-3144 M109.077271 [pii]; doi:10.1074/jbc.M109.077271.
21. Tuo QH, Zeng H, Stinnett A, Yu H, Aschner JL, et al. (2008) Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis. Am J Physiol Heart Circ Physiol 294: H2547-H2557.
22. Assmus B, Iwasaki M, Schachinger V, Roexe T, Koyanagi M, et al. (2012) Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow. Eur Heart J 33: 1911-1919 ehr388 [pii]; doi:10.1093/eurheartj/ehr388.
23. Chen JX, Stinnett A, (2008) Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice. Diabetes 57: 3335-3343.
24. Zeng H, Li L, Chen JX, (2012) Overexpression of Angiopoietin-1 Increases CD133+/c-kit+ Cells and Reduces Myocardial Apoptosis in db/db Mouse Infarcted Hearts. PLoS One 7: e35905 PONE-D-11-21968 [pii]. doi:10.1371/journal.pone.0035905.
25. Li L, Crockett E, Wang DH, Galligan JJ, Fink GD, et al. (2002) Gene transfer of endothelial NO synthase and manganese superoxide dismutase on arterial vascular cell adhesion molecule-1 expression and superoxide production in deoxycorticosterone acetate-salt hypertension. Arterioscler Thromb Vasc Biol 22: 249-255.
26. Doerries C, Grote K, Hilfiker-Kleiner D, Luchtefeld M, Schaefer A, et al. (2007) Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res 100: 894-903 01.RES.0000261657.76299.ff [pii]; doi:10.1161/01.RES.0000261657.76299.ff.
27. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, et al. (2005) Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105: 199-206 2004-05-1831 [pii]. doi:10.1182/blood-2004-05-1831.
28. Wojakowski W, Tendera M, (2005) Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. Folia Histochem Cytobiol 43: 229-232.
29. Isner JM, Asahara T, (1999) Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103: 1231-1236.
30. Yoon YS, Johnson IA, Park JS, Diaz L, Losordo DW, (2004) Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol Cell Biochem 264: 63-74.
31. Gao LR, Zhang NK, Bai J, Ding QA, Wang ZG, et al. (2010) The apelin-APJ pathway exists in cardiomyogenic cells derived from mesenchymal stem cells in vitro and in vivo. Cell Transplant 19: 949-958 ct2238gao [pii]; doi:10.3727/096368910X504450.
32. Tempel D, de BM, van Deel ED, Haasdijk RA, Duncker DJ, et al. (2012) Apelin enhances cardiac neovascularization after myocardial infarction by recruiting aplnr+ circulating cells. Circ Res 111: 585-598 CIRCRESAHA.111.262097 [pii]; doi:10.1161/CIRCRESAHA.111.262097.
33. Tanno M, Kuno A, Horio Y, Miura T, (2012) Emerging beneficial roles of sirtuins in heart failure. Basic Res Cardiol 107: 273 doi:10.1007/s00395-012-0273-5.
34. Bellizzi D, Rose G, Cavalcante P, Covello G, Dato S, et al. (2005) A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85: 258-263 S0888-7543(04)00308-8 [pii]; doi:10.1016/j.ygeno.2004.11.003.
35. Palacios OM, Carmona JJ, Michan S, Chen KY, Manabe Y, et al. (2009) Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging (Albany NY) 1: 771-783.
36. Sack MN, (2012) The role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and aging. J Mol Cell Cardiol 52: 520-525 S0022-2828(11)00470-6 [pii]; doi:10.1016/j.yjmcc.2011.11.004.
37. Pillai VB, Sundaresan NR, Jeevanandam V, Gupta MP, (2010) Mitochondrial SIRT3 and heart disease. Cardiovasc Res 88: 250-256 cvq250 [pii]; doi:10.1093/cvr/cvq250.
38. Sack MN, (2011) Emerging characterization of the role of SIRT3-mediated mitochondrial protein deacetylation in the heart. Am J Physiol Heart Circ Physiol 301: H2191-H2197 ajpheart.00199.2011 [pii]; doi:10.1152/ajpheart.00199.2011.
39. Kanamori H, Takemura G, Goto K, Maruyama R, Ono K, et al. (2011) Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion. Am J Physiol Heart Circ Physiol 300: H2261-H2271 ajpheart.01056.2010 [pii]; doi:10.1152/ajpheart.01056.2010.
40. Przyklenk K, Undyala VV, Wider J, Sala-Mercado JA, Gottlieb RA, et al. (2011) Acute induction of autophagy as a novel strategy for cardioprotection: getting to the heart of the matter. Autophagy 7: 432-433 14395 [pii].